# Syncom Formulations Q1 profit jumps 58% to Rs 24.85 crore 2026-08-17T06:17:14+00:00 | Business & Economy | Indian Opinion Desk Corroboration: 1 independent outlet Syncom Formulations (India) Ltd reported a 58 per cent rise in consolidated profit after tax to Rs 24.85 crore for the June quarter, compared with Rs 15.75 crore a year earlier, driven by an ethical prescription-led business model. Total income grew 8 per cent to Rs 133.36 crore from Rs 122.94 crore in the same period last year, the company said in a regulatory filing. Profit before tax rose 59 per cent to Rs 32.25 crore, while revenue from operations increased nearly 7 per cent to Rs 125.53 crore. Earnings per share improved to Rs 0.26 from Rs 0.17. The board recommended a final dividend of Rs 0.10 per equity share for the 2025-26 financial year, subject to shareholder approval at the annual general meeting. Chairman Ankit Kedarmal Bankda attributed the performance to quality manufacturing and long-term trust with the medical community. The company, which exports to over 15 countries, operates six divisions and a field force of over 1,000 medical representatives. Its women's healthcare brands Ovafresh and Ovafresh-M are among the leading national names in the IVF and gynaecology segment. ## Coverage - freepressjournal.in This story was synthesised by AI from the source linked above. Tags: Ankit Kedarmal Bankda, Mumbai, Syncom Formulations Canonical: https://indianopinion.org/syncom-formulations-q1-profit-jumps-58-to-rs-24-85-crore/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/syncom-formulations-q1-profit-jumps-58-to-rs-24-85-crore/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes. How this brief was made: an AI model read the report linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/